Figure 1From: Sorafenib increases 18-FDG colic uptake: demonstration in patients with differentiated thyroid cancer Visual analysis in patients treated by sorafenib. Visual analysis in patients treated by sorafenib (group 1, black), in control patients (group 2, white) and in patients treated by vandetanib or sunitinib (group 3, grey).Back to article page